Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system
- PMID: 7911558
- DOI: 10.1007/BF00169289
Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system
Abstract
Most antipsychotic drugs are, in addition to being dopamine (DA) D2 receptor antagonists, also relatively potent alpha 1 adrenoceptor antagonists. Here, we have studied the effects of the selective DA D2 receptor antagonist raclopride, alone and in combination with the selective alpha 1 adrenoceptor antagonist, prazosin, on midbrain DA neurons utilizing extracellular single cell recording techniques. As a reference compound, haloperidol (0.05-1.6 mg/kg, i.v.), a potent antagonist at both DA D2 receptors and alpha 1 adrenoceptors, was included in the electrophysiological part of the study. In addition, in vivo voltammetry was used to measure extracellular DA concentrations in the nucleus accumbens (NAC) and the dorsolateral striatum (STR) in anesthetized, pargyline pretreated rats treated with the above drugs. Raclopride (10-5120 micrograms/kg, i.v.) induced a dose dependent increase in firing rate of DA neurons in the ventral tegmental area (VTA), that was significant already at 10 micrograms/kg, and in the substantia nigra-zone compacta (SN-ZC), that reached significance at 2560 micrograms/kg. Burst firing of DA neurons was also increased in the VTA at 40 micrograms/kg, as well as in the SN-ZC at 640 micrograms/kg. A low dose of raclopride (80 micrograms/kg, cumulated dose) induced a significant increase in extracellular DA concentrations in NAC to 490% and in STR to 220%. A high dose of raclopride (2560 micrograms/kg, cumulated dose) induced a 930% increase in extracellular DA concentrations in NAC, but only a 280% increase in STR. These data demonstrate that raclopride exerts a relatively selective action on mesolimbic DA neurons. Prazosin (0.3 mg/kg, i.v.) decreased burst firing of VTA, but not SN-ZC DA neurons.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.Naunyn Schmiedebergs Arch Pharmacol. 1995 Oct;352(4):374-85. doi: 10.1007/BF00172774. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 8532065
-
The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons.Naunyn Schmiedebergs Arch Pharmacol. 1993 Apr;347(4):353-62. doi: 10.1007/BF00165384. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 8510763
-
SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.Neuropharmacology. 1999 Aug;38(8):1195-205. doi: 10.1016/s0028-3908(99)00047-7. Neuropharmacology. 1999. PMID: 10462132
-
Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs.Brain Res Brain Res Rev. 2000 Mar;31(2-3):320-9. doi: 10.1016/s0165-0173(99)00048-x. Brain Res Brain Res Rev. 2000. PMID: 10719159 Review.
-
Heterogeneity of the mesotelencephalic dopamine fibers: physiology and pharmacology.Neurosci Biobehav Rev. 2000 Jan;24(1):115-8. doi: 10.1016/s0149-7634(99)00048-2. Neurosci Biobehav Rev. 2000. PMID: 10654666 Review.
Cited by
-
Involvement of alpha1-adrenergic receptors in tranylcypromine enhancement of nicotine self-administration in rat.Psychopharmacology (Berl). 2007 Sep;193(4):457-65. doi: 10.1007/s00213-007-0799-7. Epub 2007 May 8. Psychopharmacology (Berl). 2007. PMID: 17486319
-
Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease.J Physiol. 2006 Sep 1;575(Pt 2):411-6. doi: 10.1113/jphysiol.2006.112599. Epub 2006 Jun 1. J Physiol. 2006. PMID: 16740610 Free PMC article. Review.
-
What were they thinking? Cognitive states may influence [11C]raclopride binding potential in the striatum.Neurosci Lett. 2008 Jan 3;430(1):38-42. doi: 10.1016/j.neulet.2007.10.017. Epub 2007 Dec 3. Neurosci Lett. 2008. PMID: 18060695 Free PMC article.
-
Asenapine elevates cortical dopamine, noradrenaline and serotonin release. Evidence for activation of cortical and subcortical dopamine systems by different mechanisms.Psychopharmacology (Berl). 2009 Jun;204(2):251-64. doi: 10.1007/s00213-008-1456-5. Epub 2009 Feb 7. Psychopharmacology (Berl). 2009. PMID: 19198810
-
Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.Naunyn Schmiedebergs Arch Pharmacol. 1995 Oct;352(4):374-85. doi: 10.1007/BF00172774. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 8532065
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials